NCT00411112Unknown不适用
Sentinel Node Study in Colon Cancer Surgery
University Hospital, Strasbourg, France2 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2007年3月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 140
- 试验地点
- 2
- 主要终点
- Survival without recurrence after 3 years
研究概览
简要总结
More than 20% of patients operated on for colon cancer without node metastasis will develop visceral metastases. The purpose of the study is to determine sentinel lymph nodes with two methods: blue injection and isotopic detection. Sentinel nodes will then be analyzed by immunohistochemy to detect micrometastases. No adjuvant therapy will be proposed to the patient if there are only node's micrometastases and survival will be analyzed in regard to the presence of these micrometastasis.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •colon cancer
- •open surgery
排除标准
- •emergency surgery
- •metastases
结局指标
主要结局
Survival without recurrence after 3 years
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Sentinel Lymph Node Mapping and Analysis in Colon Cancer Using Indocyanine Green DyeColon CancerNCT04351009Asian Institute of Gastroenterology, India48
已完成
2 期
Perioperative vs Postoperative Chemotherapy + Bevacizumab in Colorectal Cancer, Liver MetsLiver MetastasisColorectal CancerNCT01632722Yonsei University79
已完成
不适用
Monocentric Prospective Pilot Study Evaluating the Value of Indocyanine Green (ICG, Indocyanine Green) During a Surgical Resection of Cancerous Lesions Peritoneal Colorectal Origin.Colorectal Cancer MetastaticNCT01982227Centre Hospitalier Universitaire de Saint Etienne10
尚未招募
不适用
Sentinel Lymph Node Biopsy in Rectal CancerRectal Cancer Stage IIIRectal Cancer Stage IVNCT05830890National Cancer Center, China87
终止
不适用
In colorectal metastases patients who require liver resection, does a surgeon having knowledge of liver fat measurements influence surgical planning decisions that result in improved patient outcomes.ACTRN12615000567527Resonance Health Ltd20
